Fentanyl Injectable

Fentanyl Injectable

Form: Injectable (IV, IM, SC)

Strength: 50 mcg/mL, 100 mcg/mL, 200 mcg/mL

Reference Brands: Durogesic(US & EU)

Category: Analgesic

Fentanyl injection is approved in the EU and US for anesthesia induction, pain management, and as part of anesthesia protocols. In the EU, brands like Durogesic are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, biosimilarity, and pharmacovigilance. Both regions require detailed dossiers for initial approval and continuous safety monitoring. Due to high abuse potential, strict control measures are enforced. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for fentanyl injection products while ensuring adherence to European and US standards for safe, effective opioid therapy.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Dexketoprofen + Tramadol tablets

Strength: 25 mg dexketoprofen + 37.5 mg tramadol

Form: Tablets

Reference Brands: Enantyum(EU)

View Details Get Enquiry
Paracetamol + Codeine tablets

Strength: 300 mg paracetamol + 30 mg codeine; 300 mg + 60 mg

Form: Tablets

Reference Brands: Tylenol with Codeine(US)

View Details Get Enquiry
Aceclofenac + Paracetamol tablets

Strength: 100 mg Aceclofenac + 325 mg Paracetamol

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details Get Enquiry
Tramadol + Paracetamol tablets

Strength: 37.5 mg tramadol + 325 mg paracetamol; 75 mg + 650 mg

Form: Oral Tablets

Reference Brands: Ultracet(US); Tramacet(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.